Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Erythroblastic, Acute × tanespimycin × Clear all

Sponsor

Conditions

von Hippel-Lindau Disease 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Kidney Neoplasms 1 Hodgkin Disease 1 Carcinoma, Renal Cell 1 Carcinoma, Medullary 1 Breast Neoplasms 1 Adenocarcinoma, Follicular 1

Interventions

Cytarabine 21 fludarabine phosphate 9 Mitoxantrone 8 Busulfan 7 Idarubicin 6 Daunorubicin 6 Whole-Body Irradiation 5 Peripheral Blood Stem Cell Transplantation 5 Methotrexate 5 Gemtuzumab 5 Etoposide 5 alvocidib 4 Vorinostat 4 Filgrastim 4 Cyclosporine 4 Cyclophosphamide 4 Clofarabine 4 Azacitidine 4 Antilymphocyte Serum 4 tipifarnib 3 Tacrolimus 3 Mycophenolic Acid 3 Flow Cytometry 3 Decitabine 3 Bortezomib 3 fludarabine 2 aldesleukin 2 Pravastatin 2 Observation 2 In Situ Hybridization, Fluorescence 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡